Melanocortin-1 receptor (MC1R) genotypes do not correlate with size in two cohorts of medium-to-giant congenital melanocytic nevi Institutional affiliations

Neus Calbet-Llopart (1) , Mirella Pascini-Garrigos (1) , Gemma Tell-Martí (1, 2) , Miriam Potrony (1, 2) , Vanessa Martins da Silva (1) , Alicia Barreiro (1) , Susana Puig (1, 2) , Guillaume Captier (3) , Isabelle James (4) , Nathalie Degardin (5, 6) , Cristina Carrera (1, 2) , Josep Malvehy (1, 2) , Heather Etchevers (6) , Joan Anton Puig-Butillé (2, 1)

1 IDIBAPS - Institut d'Investigacions Biomèdiques August Pi i Sunyer
2 CIBER de Enfermedades Raras (CIBERER)
3 CHU Montpellier
4 Clinique du Val d'Ouest
5 TIMONE - Hôpital de la Timone [CHU - APHM]
6 MMG - Marseille medical genetics - Centre de génétique médicale de Marseille

Congenital melanocytic nevi (CMN) are cutaneous malformations whose prevalence is inversely correlated with projected adult size. CMN are caused by somatic mutations, but epidemiological studies suggest that germline genetic factors may influence CMN development. In CMN patients from the U.K., genetic variants in the MC1R gene, such as p.V92M and loss-of-function variants, have been previously associated with larger CMN. We analyzed the association of MC1R variants with CMN characteristics in 113 medium-to-giant CMN patients from Spain and from a distinct cohort of 53 patients from France, Norway, Canada and the U.S. These cohorts were similar at the clinical and phenotypical level, except for the number of nevi per patient. We found that the p.V92M or loss-of-function MC1R variants either alone or in combination did not correlate with CMN size, in contrast to the U.K. CMN patients. An additional case-control analysis with 259 unaffected Spanish individuals, showed a higher frequency of MC1R compound heterozygous or homozygous variant genotypes in Spanish CMN patients compared to the control population (15.9% vs. 9.3%; P=0.075). Altogether, this study suggests that MC1R variants are not associated with CMN size in these non-U.K. cohorts. Additional studies are required to define the potential role of MC1R as a risk factor in CMN development.

Mots clés: Congenital melanocytic nevi or nevus; melanocortin 1 receptor (MC1R) gene; nevogenesis; cutaneous lesion; inherited variants; Giant Congenital Melanocytic Nevus (GCMN); phenotype; population.

Domaines: Médecine humaine et pathologie; Dermatologie; Génétique

Neus Calbet-Llopart, Mirella Pascini-Garrigos, Gemma Tell-Martí, Miriam Potrony, Vanessa Martins da Silva, et al.. Melanocortin-1 receptor (MC1R) genotypes do not correlate with size in two cohorts of medium-to-giant congenital melanocytic nevi Institutional affiliations. 2020. ⟨hal-02540105⟩